Healthcare provider profile · identity verified

Sandip Patel, M.D

Allopathic & Osteopathic Physicians|Internal Medicine · TOMS RIVER, NJ · NPI 1316225659

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Sandip Patel, M.D received $236.66 in general payments during 2025 across 7 reported records.

Tarsus Pharmaceuticals, Inc. accounted for 49.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$236.66

7 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Tarsus Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$117.88	49.8%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$63.68	26.9%	3	2025
Bausch & Lomb Americas Inc.	Unresolved — no canonical attribution shown	$21.22	9.0%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$18.57	7.8%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$15.31	6.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$236.66	7

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
XDEMVY Normalized: xdemvy	Drug	Tarsus Pharmaceuticals, Inc.	$117.88	1	2025
Source payment records 2025-05-08 · Tarsus Pharmaceuticals, Inc. · $117.88 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$45.40	2	2025
Source payment records 2025-03-04 · Exact Sciences Corporation · $23.72 · Open Payments source 2025-06-09 · Exact Sciences Corporation · $21.68 · Open Payments source
MIEBO Normalized: miebo	Drug	Bausch & Lomb Americas Inc.	$21.22	1	2025
Source payment records 2025-07-01 · Bausch & Lomb Americas Inc. · $21.22 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.57	1	2025
Source payment records 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $18.57 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$18.28	1	2025
Source payment records 2025-11-17 · Exact Sciences Corporation · $18.28 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$15.31	1	2025
Source payment records 2025-02-06 · Otsuka America Pharmaceutical, Inc. · $15.31 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1894	282
Pantoprazole Sodium	Pantoprazole Sodium	1140	154
Furosemide	Furosemide	950	148
Levothyroxine Sodium	Levothyroxine Sodium	894	133
Amlodipine Besylate	Amlodipine Besylate	851	116
Eliquis	Apixaban	770	102
Donepezil Hcl	Donepezil Hcl	761	68
Gabapentin	Gabapentin	639	86
Lisinopril	Lisinopril	596	83
Metoprolol Succinate	Metoprolol Succinate	562	93
Potassium Chloride	Potassium Chloride	531	83
Tamsulosin Hcl	Tamsulosin Hcl	490	90
Escitalopram Oxalate	Escitalopram Oxalate	487	69
Losartan Potassium	Losartan Potassium	480	81
Metformin Hcl	Metformin Hcl	475	70
Mirtazapine	Mirtazapine	455	48
Duloxetine Hcl	Duloxetine Hcl	383	32
Buspirone Hcl	Buspirone Hcl	381	44
Trazodone Hcl	Trazodone Hcl	377	59
Divalproex Sodium	Divalproex Sodium	374	39
Sertraline Hcl	Sertraline Hcl	374	57
Finasteride	Finasteride	349	48
Metoprolol Tartrate	Metoprolol Tartrate	348	54
Simvastatin	Simvastatin	316	46
Omeprazole	Omeprazole	294	66
Carvedilol	Carvedilol	293	50
Clopidogrel	Clopidogrel Bisulfate	286	54
Xarelto	Rivaroxaban	273	33
Quetiapine Fumarate	Quetiapine Fumarate	256	40
Spironolactone	Spironolactone	244	40
Carbidopa-Levodopa	Carbidopa/Levodopa	214	22
Montelukast Sodium	Montelukast Sodium	211	25
Rosuvastatin Calcium	Rosuvastatin Calcium	208	44
Allopurinol	Allopurinol	206	34
Januvia	Sitagliptin Phosphate	203	26
Memantine Hcl	Memantine Hcl	201	27
Famotidine	Famotidine	191	34
Hydralazine Hcl	Hydralazine Hcl	187	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	184	31
Pravastatin Sodium	Pravastatin Sodium	177	26
Torsemide	Torsemide	176	33
Nifedipine Er	Nifedipine	173	29
Albuterol Sulfate Hfa	Albuterol Sulfate	165	56
Farxiga	Dapagliflozin Propanediol	159	27
Levetiracetam	Levetiracetam	148	19
Oxybutynin Chloride Er	Oxybutynin Chloride	140	12
Ropinirole Hcl	Ropinirole Hcl	139	14
Hydrochlorothiazide	Hydrochlorothiazide	133	27
Midodrine Hcl	Midodrine Hcl	132	24
Glipizide	Glipizide	131	26
Breo Ellipta	Fluticasone/Vilanterol	125	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	121	26
Citalopram Hbr	Citalopram Hydrobromide	119	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	114	32
Paroxetine Hcl	Paroxetine Hcl	111	11
Alprazolam	Alprazolam	105	35
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	91	22
Valsartan	Valsartan	91	14
Lactulose	Lactulose	90	25
Fluoxetine Hcl	Fluoxetine Hcl	88	14
Latanoprost	Latanoprost	87	20
Nystatin	Nystatin	84	39
Lamotrigine	Lamotrigine	83	suppressed
Azithromycin	Azithromycin	82	72
Digoxin	Digoxin	82	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	82	18
Diclofenac Sodium	Diclofenac Sodium	81	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	20
Sucralfate	Sucralfate	79	16
Alendronate Sodium	Alendronate Sodium	78	17
Atenolol	Atenolol	76	15
Warfarin Sodium	Warfarin Sodium	75	suppressed
Perphenazine	Perphenazine	73	suppressed
Meloxicam	Meloxicam	71	16
Bupropion Xl	Bupropion Hcl	70	suppressed
Myrbetriq	Mirabegron	70	suppressed
Lorazepam	Lorazepam	69	25
Cephalexin	Cephalexin	66	35
Humalog Kwikpen U-100	Insulin Lispro	66	19
Pregabalin	Pregabalin	64	suppressed
Diltiazem Hcl	Diltiazem Hcl	63	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	63	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	62	16
Glipizide Er	Glipizide	62	11
Prednisone	Prednisone	61	18
Pioglitazone Hcl	Pioglitazone Hcl	60	suppressed
Bumetanide	Bumetanide	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	55	suppressed
Ezetimibe	Ezetimibe	53	16
Clonazepam	Clonazepam	52	12
Enalapril Maleate	Enalapril Maleate	52	12
Metformin Hcl Er	Metformin Hcl	50	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	49	suppressed
Repaglinide	Repaglinide	49	12
Cefuroxime	Cefuroxime Axetil	48	34
Topiramate	Topiramate	48	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	47	42
Ondansetron Hcl	Ondansetron Hcl	46	28
Nebivolol Hcl	Nebivolol Hcl	44	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	43	27
Nystop	Nystatin	43	26
Doxycycline Hyclate	Doxycycline Hyclate	42	24
Oxycodone Hcl	Oxycodone Hcl	42	13
Tolterodine Tartrate Er	Tolterodine Tartrate	42	suppressed
Acetazolamide	Acetazolamide	41	suppressed
Baclofen	Baclofen	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	17
Nateglinide	Nateglinide	41	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	13
Risperidone	Risperidone	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Aripiprazole	Aripiprazole	39	suppressed
Restasis	Cyclosporine	39	suppressed
Fenofibrate	Fenofibrate,micronized	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	37	suppressed
Glimepiride	Glimepiride	37	suppressed
Relistor	Methylnaltrexone Bromide	37	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	21
Glatiramer Acetate	Glatiramer Acetate	36	suppressed
Olanzapine	Olanzapine	36	suppressed
Tradjenta	Linagliptin	36	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	34	34
Entresto	Sacubitril/Valsartan	34	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	22
Amiodarone Hcl	Amiodarone Hcl	33	11
Amoxicillin	Amoxicillin	33	18
Nyamyc	Nystatin	32	12
Verapamil Er	Verapamil Hcl	32	suppressed
Timolol Maleate	Timolol Maleate	31	suppressed
Alogliptin	Alogliptin Benzoate	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	13
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Lurasidone Hcl	Lurasidone Hcl	28	suppressed
Methylprednisolone	Methylprednisolone	28	27
Pyridostigmine Bromide	Pyridostigmine Bromide	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	11
Lansoprazole	Lansoprazole	27	suppressed
Levofloxacin	Levofloxacin	27	21
Lumigan	Bimatoprost	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Ammonium Lactate	Ammonium Lactate	24	15
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Creon	Lipase/Protease/Amylase	23	suppressed
Amantadine	Amantadine Hcl	22	suppressed
Budesonide	Budesonide	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Rivastigmine	Rivastigmine Tartrate	22	suppressed
Fentanyl	Fentanyl	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	13
Cyclosporine	Cyclosporine	20	suppressed
Dapagliflozin	Dapagliflozin Propanediol	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Tivicay	Dolutegravir Sodium	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Combigan	Brimonidine Tartrate/Timolol	18	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Acarbose	Acarbose	17	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Letrozole	Letrozole	16	suppressed
Loperamide	Loperamide Hcl	16	11
Multaq	Dronedarone Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Rytary	Carbidopa/Levodopa	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Enulose	Lactulose	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Methimazole	Methimazole	15	suppressed
Temazepam	Temazepam	15	suppressed
Vraylar	Cariprazine Hcl	15	suppressed
Budesonide Dr	Budesonide	14	suppressed
Clozapine	Clozapine	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ingrezza	Valbenazine Tosylate	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Novolin R Flexpen	Insulin Regular, Human	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Linzess	Linaclotide	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Procrit	Epoetin Alfa	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Easy Touch Safety Pen Needle	Pen Needle, Diabetic, Safety	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glyburide	Glyburide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Santyl	Collagenase Clostridium Hist.	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	11	suppressed
Ozempic	Semaglutide	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$236.66 · 7 records	Tarsus Pharmaceuticals, Inc.	CAPLYTA, Cologuard Collection Kit, MIEBO, REXULTI, The Cologuard Plus Collection Kit, XDEMVY	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error